About Haohong Pharmaceutical

Haohong (Qihe) Pharmaceutical Technology Co., Ltd. is located in the High-tech Zone of Qihe County, Shandong Province, adjacent to the Yellow River and within the Jinan Economic Circle, enjoying convenient transportation. The company specializes in the R&D and custom production of innovative active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It passed the ISO 9001:2015 quality management system certification in 2021, was recognized as a Technology-based Small and Medium-sized Enterprise in 2024, and awarded Innovative Small and Medium-sized Enterprise of Shandong Province in 2025.

Haohong has a high-level R&D team and a full range of analytical testing instruments and methods. At present, its production base in Liaocheng is equipped with 30 sets of 3,000–5,000L reactors, with an annual production capacity of 1,000 tons.

The company focuses on the development of active pharmaceutical ingredients and intermediates for anti-cancer, anti-hepatitis C and anti-diabetic therapies, with an emphasis on high-grade intermediates. Its main products include Bicalutamide, Enzalutamide, Apalutamide, Darolutamide, Abemaciclib, Venetoclax, Macitentan, Empagliflozin, Larotrectinib, Apixaban, Rivaroxaban, Ibrutinib, Ceritinib, Pomalidomide, Lenalidomide, Ivacaftor, Tofacitinib, Cabozantinib, Alectinib, etc.

Our products are exported to overseas markets including the United States, Europe, Japan, India, Bangladesh and other regions. The company currently has dozens of high-grade intermediates available for commercial production, and also provides customers with efficient custom synthesis services ranging from gram scale to hundreds of kilograms.

Adhering to the corporate philosophy of "Pragmatism, Innovation, Integrity", Haohong is committed to serving global customers with full dedication!
🎓
World-Class Team
Graduates from top universities worldwide
🔬
Advanced R&D
Self-developed
🤖
Innovation Focus
Multiple innovative technologies

Our Products

View All Products →
4-Cyclopropyl-2-Fluorobenzoic Acid CAS 1247927-81-6 Pharmaceutical Intermediate

4-Cyclopropyl-2-Fluorobenzoic Acid CAS 1247927-81-6 Pharmaceutical Intermediate

Model: 4-cyclopropyl-2-fluorobenzoic acid
Parameters: 1692983377

5,7-Di-tert-butyl-3-phenylbenzo[d]oxazol-3-ium Tetrafluoroborate

5,7-Di-tert-butyl-3-phenylbenzo[d]oxazol-3-ium Tetrafluoroborate

Model: 5,7-Di-tert-butyl-3-phenylbenzo[d]oxazol-3-ium tetrafluoroborate
Parameters: 0755200543

High Purity 3-(Methylamino)-1-Propanol CAS 42055-15-2 for Pharmaceutical Synthesis

High Purity 3-(Methylamino)-1-Propanol CAS 42055-15-2 for Pharmaceutical Synthesis

Model: 3-(METHYLAMINO)-1-PROPANOL
Parameters: 1757282343

Quinuclidine CAS 100-76-5 High-Purity Pharmaceutical Intermediate for API Synthesis

Quinuclidine CAS 100-76-5 High-Purity Pharmaceutical Intermediate for API Synthesis

Model: QUINUCLIDINE
Parameters: 7495595213

1-Ethyladamantane High-Purity Pharmaceutical Intermediate CAS 770-69-4

1-Ethyladamantane High-Purity Pharmaceutical Intermediate CAS 770-69-4

Model: 1-ETHYLADAMANTANE
Parameters: 0057581657

2-Amino-4-Nitroanisole CAS 99-59-2 for Pharmaceutical Intermediates

2-Amino-4-Nitroanisole CAS 99-59-2 for Pharmaceutical Intermediates

Model: 2-Amino-4-nitro anisidine
Parameters: 7842460922

2,6-Diiodo-4-nitroaniline CAS 5398-27-6 Pharmaceutical Intermediate

2,6-Diiodo-4-nitroaniline CAS 5398-27-6 Pharmaceutical Intermediate

Model: 2,6-DIIODO-4-NITROANILINE
Parameters: 0063315734

4-Nitro-L-Phenylalanine CAS 949-99-5 Pharmaceutical Intermediate

4-Nitro-L-Phenylalanine CAS 949-99-5 Pharmaceutical Intermediate

Model: 4-Nitro-3-phenyl-L-alanine
Parameters: 5213928285

CAS 80430-23-5 Methyl 2-[(Methylsulfonyl)oxy]-5-nitrobenzoate Pharmaceutical Intermediate

CAS 80430-23-5 Methyl 2-[(Methylsulfonyl)oxy]-5-nitrobenzoate Pharmaceutical Intermediate

Model: methyl 2-[(methylsulphonyl)oxy]-5-nitrobenzoate
Parameters: 7517512366

CAS 35320-23-1 (R)-(-)-2-Amino-1-propanol 98% ee Pharmaceutical Intermediate

CAS 35320-23-1 (R)-(-)-2-Amino-1-propanol 98% ee Pharmaceutical Intermediate

Model: (R)-(-)-2-Amino-1-propanol
Parameters: 9465703397

2-(Trifluoromethyl)Benzylamine CAS 3048-01-9 for Pharmaceutical Synthesis

2-(Trifluoromethyl)Benzylamine CAS 3048-01-9 for Pharmaceutical Synthesis

Model: 2-(TRIFLUOROMETHYL)BENZYLAMINE
Parameters: 5267168890

High-Purity 7-Nitroindole CAS 6960-42-5 for Pharmaceutical Synthesis

High-Purity 7-Nitroindole CAS 6960-42-5 for Pharmaceutical Synthesis

Model: 7-Nitroindole
Parameters: 5238483848

2,3,4,6-Tetra-O-Benzyl-D-Glucono-1,5-Lactone CAS 13096-62-3 for Pharmaceutical Intermediates

2,3,4,6-Tetra-O-Benzyl-D-Glucono-1,5-Lactone CAS 13096-62-3 for Pharmaceutical Intermediates

Model: 2,3,4,6-TETRA-O-BENZYL-D-GLUCONO-1,5-LACTONE
Parameters: 5916377665

4-Bromo-2,6-Difluoroaniline CAS 1868-81-7 for Abemaciclib Intermediate

4-Bromo-2,6-Difluoroaniline CAS 1868-81-7 for Abemaciclib Intermediate

Model: 4-Bromo-2,6-difluoroaniline 5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine 2-Bromo-5-formylpyridine 4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Parameters: 4431737227

5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine CAS 398565-53-2 for Abemaciclib Synthesis

5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine CAS 398565-53-2 for Abemaciclib Synthesis

Model: 4-Bromo-2,6-difluoroaniline 5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine 2-Bromo-5-formylpyridine 4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Parameters: 690872624X

2-Bromo-5-formylpyridine CAS 100422-52-6 for Abemaciclib Synthesis

2-Bromo-5-formylpyridine CAS 100422-52-6 for Abemaciclib Synthesis

Model: 4-Bromo-2,6-difluoroaniline 5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine 2-Bromo-5-formylpyridine 4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Parameters: 8820573202

4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole CAS 1356339-86-7

4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole CAS 1356339-86-7

Model: 4-Bromo-2,6-difluoroaniline 5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-amine 2-Bromo-5-formylpyridine 4-Fluoro-2-methyl-1-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
Parameters: 7161032008

Alectinib Intermediate 2-(4-Ethylphenyl)-2-Methylpropanoic Acid CAS 1247119-83-0

Alectinib Intermediate 2-(4-Ethylphenyl)-2-Methylpropanoic Acid CAS 1247119-83-0

Model: 2-(4-Ethylphenyl)-2-methylpropanoic acid 2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
Parameters: 0964070340

Alectinib Intermediate 2-(4-Ethyl-3-Iodophenyl)-2-Methylpropanoic Acid CAS 1256584-73-2

Alectinib Intermediate 2-(4-Ethyl-3-Iodophenyl)-2-Methylpropanoic Acid CAS 1256584-73-2

Model: 2-(4-Ethylphenyl)-2-methylpropanoic acid 2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
Parameters: 9874680342

Alectinib Key Intermediate tert-Butyl 6-Cyano-2-(2-(4-Ethyl-3-Iodophenyl)Propan-2-Yl)-1H-Indole-3-Carboxylate

Alectinib Key Intermediate tert-Butyl 6-Cyano-2-(2-(4-Ethyl-3-Iodophenyl)Propan-2-Yl)-1H-Indole-3-Carboxylate

Model: 2-(4-Ethylphenyl)-2-methylpropanoic acid 2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
Parameters: 9331423470

Company Gallery

Factory
Factory
Laboratory
Laboratory
Reactor
Reactor
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Product Introduction
Company Introduction
Company Introduction
Company Introduction
Company Introduction

Certifications & Awards

Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
Utility Model Patent
ISO 9001:2015 Quality Management System Certificate
ISO 9001:2015 Quality Management System Certificate

Success Stories & Case Studies

Top-tier Pharmaceutical Group

Top-tier Pharmaceutical Group

1High reaction yield reduces the production cost of finished pharmaceuticals.
2Low levels of impurities, heavy metals and residual solvents minimize drug safety risks.
3Stable quality across batches improves the consistency of customers’ pharmaceutical production.
4Simplified downstream synthesis processes shorten drug development cycles.
5Accelerates the drug registration process.
Ultra‑high purity with strictly controlled impurities, heavy metals and residual solvents.
Consistent quality batch‑to‑batch, stable crystal form and particle size.
Strict compliance with ICH, GMP and international pharmaceutical standards.
Stable large‑scale production capacity and reliable supply chain.
Customizable R&D support for API synthesis and drug registration.

Location: US,AE,AU,BD,CA,CN,DE,FR,KR,SA,GB,IN,SG,SE 📦 Quantity: 200

Company & Product Videos

▶

Company Introduction & Factory Tour

⏱ Duration: 3:45 | 👁 Views: 15,230

▶

Product Demonstration - Kestrel K-1

⏱ Duration: 5:12 | 👁 Views: 28,450

▶

Technology Innovation Showcase

⏱ Duration: 4:30 | 👁 Views: 12,890

▶

Customer Testimonials & Success Stories

⏱ Duration: 6:20 | 👁 Views: 9,650

Ready to Transform Your Life?

Contact us immediately to learn how our products meet your needs.